IA
MGNX icon

Inspire Advisors’s MacroGenics MGNX Stock Holding History

Inspire Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19
Closed – – 469
2020
Q4 		$0 Buy
+19
New +$437 ﹤0.01% 805

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Inspire Advisors's MGNX Position: Q1 2021 in Review

Inspire Advisors sold out of MacroGenics (MGNX) in Q1 2021, closing a stake of 19 shares.

Inspire Advisors first reported a position in MGNX in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 173 funds tracked by Wall St. Rank hold MGNX as of Q1 2021.

  • Inspire Advisors reported no remaining MacroGenics position as of Q1 2021 after selling out during the quarter.
  • Inspire Advisors sold 19 MacroGenics shares in Q1 2021.
  • Inspire Advisors first reported a position in MacroGenics in Q4 2020 and held it in 1 quarter.
  • Inspire Advisors's MacroGenics position peaked at $0 in Q4 2020.
  • 173 funds tracked by Wall St. Rank held MacroGenics as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.